See All Slides - tctmd.com

Slides

Presentation

Two-Year Results Following Treatment with the Stellarex DCB: ILLUMENATE FIH Study

Presenter: S. Duda

May 29, 2014

Presentation

Delay in Filling First Clopidogrel Prescription after Coronary Stenting Is Associated with an Increased Risk of Death and MI

Presenter: Nicholas L. Cruden

May 28, 2014

Presentation

Trimetazidine Impacts on Myocardial Injury and CIN in Diabetic Patients with RD Undergoing Elective PCI

Presenter: Mohamed A. Shehata

May 27, 2014

Presentation

30-day Outcomes from the Sapien 3 Trial

Presenter: John Webb

May 23, 2014

Presentation EuroPCR 2014

Predictors of nonresponse to renal denervation in a real world population of patients with uncontrolled hypertension: Analysis of the Global SYMPLICITY Registry

Presenter: Felix Mahfoud

May 22, 2014

Presentation EuroPCR 2014

Final Five-year Outcomes from the Randomized Comparison of Zotarolimus-eluting Stents With Everolimus-eluting Stents in the RESOLUTE All Comers Trial

Presenter: Stephan Windecker

May 22, 2014

Presentation EuroPCR 2014

Final Five Year Outcomes of the NOBORI2 Trial

Presenter: G.B. Danzi

May 22, 2014

Presentation EuroPCR 2014

Two-year clinical outcome after left atrial appendage closure with the Amplatzer Cardiac Plug device in patients with non-valvular atrial fibrillation and contraindications for anticoagulation therapy

Presenter: Jos? Ram?n L?pez-M?nguez

May 21, 2014

$Routine bivalirudin is superior to unfractionated heparin + bailout GP IIb/IIIa inhibitors in patients with STEMI transported for primary PCI: A prespecified subgroup analysis of the EUROMAX trial$

Presentation EuroPCR 2014

Routine bivalirudin is superior to unfractionated heparin + bailout GP IIb/IIIa inhibitors in patients with STEMI transported for primary PCI: A prespecified subgroup analysis of the EUROMAX trial

Presenter: Uwe Zeymer

May 21, 2014

Presentation EuroPCR 2014

Post‐Market Surveillance Study of Paclitaxel‐Eluting Nitinol Stents for Treating FemoropoplitealArtery Disease in Japan: 12‐Month Results

Presenter: Hiroyoshi Yokoi

May 21, 2014

Advertisement

Slides

Two-Year Results Following Treatment with the Stellarex DCB: ILLUMENATE FIH Study

Delay in Filling First Clopidogrel Prescription after Coronary Stenting Is Associated with an Increased Risk of Death and MI

Trimetazidine Impacts on Myocardial Injury and CIN in Diabetic Patients with RD Undergoing Elective PCI

30-day Outcomes from the Sapien 3 Trial

Predictors of nonresponse to renal denervation in a real world population of patients with uncontrolled hypertension: Analysis of the Global SYMPLICITY Registry

Final Five-year Outcomes from the Randomized Comparison of Zotarolimus-eluting Stents With Everolimus-eluting Stents in the RESOLUTE All Comers Trial

Final Five Year Outcomes of the NOBORI2 Trial

Two-year clinical outcome after left atrial appendage closure with the Amplatzer Cardiac Plug device in patients with non-valvular atrial fibrillation and contraindications for anticoagulation therapy

Routine bivalirudin is superior to unfractionated heparin + bailout GP IIb/IIIa inhibitors in patients with STEMI transported for primary PCI: A prespecified subgroup analysis of the EUROMAX trial

Post‐Market Surveillance Study of Paclitaxel‐Eluting Nitinol Stents for Treating FemoropoplitealArtery Disease in Japan: 12‐Month Results

Search Slides

Advertisement

Advertisement

Slides

Search Slides

Sign Up for Our Newsletter

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content